Cargando…

Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.

Detalles Bibliográficos
Autores principales:	Lissoni, P., Tancini, G., Rovelli, F., Cattaneo, G., Archili, C., Barni, S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971518/ https://www.ncbi.nlm.nih.gov/pubmed/2245177

Ejemplares similares

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
por: Lissoni, P., et al.
Publicado: (1989)

Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
por: Lissoni, P., et al.
Publicado: (1991)

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
por: Lissoni, P., et al.
Publicado: (1994)

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
por: Lissoni, P., et al.
Publicado: (1993)

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
por: Lissoni, P., et al.
Publicado: (1992)

Evidence for altered opioid activity in patients with cancer.
por: Lissoni, P., et al.
Publicado: (1987)

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy
por: Fumagalli, L, et al.
Publicado: (1999)

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.
por: Lissoni, P., et al.
Publicado: (1995)

A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
por: Lissoni, P., et al.
Publicado: (1996)

The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results
por: Lissoni, Paolo, et al.
Publicado: (2017)

In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients.
por: Lissoni, P., et al.
Publicado: (1998)

Interleukine-2 serum level in breast cancer patients
por: Harjianti, Tutik, et al.
Publicado: (2023)

Maternal serum iron status, hepcidin and interleukin-6 levels in women with preeclampsia
por: Ahmed, Yasir I. B., et al.
Publicado: (2023)

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer.
por: Scambia, G., et al.
Publicado: (1995)

Lower serum interleukin‐22 and interleukin‐35 levels are associated with disease status in neuromyelitis optica spectrum disorders
por: Yang, Hong, et al.
Publicado: (2019)

Serum levels of interleukin 6 in patients with lung cancer.
por: Yanagawa, H., et al.
Publicado: (1995)

Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients
por: Messina, Giuseppina, et al.
Publicado: (2010)

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
por: Marino, P., et al.
Publicado: (1990)

Interleukin-6 serum level and monocyte production in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1992)

Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes
por: Hou, Ya-Chin, et al.
Publicado: (2018)

Comparison of serum creatinine and spot urine interleukin-18 levels following radiocontrast administration
por: Turkmen, F., et al.
Publicado: (2012)

Insulin Resistance and Serum Levels of Interleukin-17 and Interleukin-18 in Normal Pregnancy
por: Jahromi, Abdolreza Sotoodeh, et al.
Publicado: (2014)

Association between Serum Levels of Interleukin-6 and Stage of Laryngeal Cancer
por: Nikakhlagh, Soheila, et al.
Publicado: (2015)

Serum Interleukin-27 Level in Different Clinical Stages of Lung Cancer
por: Babadi, Akbar Soleimani, et al.
Publicado: (2019)

Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma
por: Zhang, Jianwei, et al.
Publicado: (2022)

Serum Levels of Soluble Interleukin-2 Receptor in Pulmonary Tuberculosis
por: Choi, Soo Jeon, et al.
Publicado: (1990)

Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
por: Choy, Ernest H S, et al.
Publicado: (2018)

Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study
por: Mavropoulou, Eirini, et al.
Publicado: (2020)

Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells
por: Samiea, Abrar, et al.
Publicado: (2020)

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
por: Sobjanek, Michal, et al.
Publicado: (2016)

Is There Any Relation between Serum Levels of Interleukin-10 and Neurophysiological Abnormalities in Bell’s Palsy?
por: Maghbooli, Mehdi, et al.
Publicado: (2021)

Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
por: Nakata, B., et al.
Publicado: (1998)

Serum levels of interleukin-6 and interleukin-8 as diagnostic markers of acute pyelonephritis in children
por: Mahyar, Abolfazl, et al.
Publicado: (2013)

Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
por: Othman, Mohamed S., et al.
Publicado: (2013)

Serum levels of interleukin-6 are not dependent on the kidney function
por: Nässberger, L.
Publicado: (1992)

Interleukin-33 serum levels in postmenopausal women with osteoporosis
por: Ginaldi, Lia, et al.
Publicado: (2019)

Decreased levels of interleukin 27 in the serum of vitiligo patients()()
por: Hosseini, Saeed Malek, et al.
Publicado: (2020)

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1987)

Effect of Nonsurgical Periodontal Therapy on Serum Levels of Interleukin-1β and Interleukin-8 in Smokers and Nonsmokers with Chronic Periodontitis
por: Vijayakumar, Steffi, et al.
Publicado: (2020)

Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations
por: Yavropoulou, Maria P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kl7dqvfm9c6cnui8h2urssmg0l